IP Library Granted Patent US 8,048,624
Granted Patent B1
US 8,048,624 · App. 12/328,588 · Granted Nov 1, 2011

Compositions and methods for 3-hydroxypropionate bio-production from biomass

Assignee: OPX Biotechnologies, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,048,624
App. No.
12/328,588
Granted
Nov 1, 2011
Kind
B1
Abstract

Methods of obtaining mutant nucleic acid sequences that demonstrate elevated oxaloacetate α-decarboxylase activity are provided. Compositions, such as genetically modified microorganisms that comprise such mutant nucleic acid sequences, are described, as are methods to obtain the same.

Claims (26)

1. A recombinant bacterium transformed with at least one exogenous nucleic acid that encodes 3-hydroxypropanoic acid (3-HP) pathway enzymes, wherein said 3-HP pathway enzymes comprise a 2-keto acid decarboxylase and a dehydrogenase, and wherein production of 3-HP is enhanced as compared to a bacterium without the exogenous nucleic acid.

2. The recombinant bacterium of claim 1 , further comprising an exogenous nucleic acid that encodes a phosphoenolpyruvate carboxykinase.

3. The recombinant bacterium of claim 1 , wherein at least one exogenous nucleic acid is a heterologous nucleic acid.

4. The recombinant bacterium of claim 1 , wherein said bacterium is in an anaerobic culture medium.

5. The recombinant bacterium of claim 1 , wherein said dehydrogenase converts malonate semialdehyde to 3-HP.

6. The recombinant bacterium of claim 1 , wherein said dehydrogenase is a 3-hydroxypropionate dehydrogenase that converts malonate semialdehyde to 3-HP.

7. A method for producing 3-HP, comprising culturing the recombinant bacterium of claim 1 under conditions and for a sufficient period of time to produce 3-HP.

8. The method of claim 7 , wherein at least one exogenous nucleic acid is a heterologous nucleic acid.

9. The method of claim 7 , wherein said bacterium is in an anaerobic culture medium.

10. The method of claim 7 , wherein said dehydrogenase converts malonate semialdehyde to 3-HP.

11. The method of claim 7 , wherein said dehydrogenase is a 3-hydroxypropionate dehydrogenase that converts malonate semialdehyde to 3-HP.

12. A recombinant bacterium comprising a pathway modified for enhanced production of 3-hydroxypropionic acid (3-HP), wherein said bacterium is transformed with at least one heterologous nucleic acid that encodes enzymes of a 3-HP pathway, said enzymes comprise an oxaloacetate alpha-oxo-decarboxylase and a dehydrogenase, thereby enhancing a 3-HP bio-production process in said bacterium.

13. The recombinant bacterium of claim 12 , further comprising a heterologous nucleic acid that expresses the enzymatic activity of phosphoenolpyruvate carboxykinase for the pathway.

14. The recombinant bacterium of claim 12 , wherein at least one heterologous nucleic acid is a foreign nucleic acid.

15. The recombinant bacterium of claim 12 , wherein the bio-production of 3-HP is performed under anaerobic conditions.

16. The recombinant bacterium of claim 12 , wherein the bio-production of 3-HP is performed under microaerobic conditions.

17. The recombinant bacterium of claim 12 , wherein the dehydrogenase converts malonate semialdehyde to 3-HP.

18. The recombinant bacterium of claim 12 , wherein the dehydrogenase is 3-hydroxypropionate dehydrogenase.

19. A method for enhanced production of 3-hydroxypropionic acid (3-HP), the method comprising culturing the recombinant bacterium of claim 12 under suitable bio-production conditions for a suitable time to obtain enhanced bio-production of 3-HP.

20. The method of claim 19 , wherein at least one heterologous nucleic acid is a foreign nucleic acid.

21. The method of claim 19 , wherein the bio-production of 3-HP is performed under aerobic conditions.

22. The method of claim 19 , wherein the bio-production of 3-HP is performed under anaerobic conditions.

23. The method of claim 19 , wherein the bio-production of 3-HP goes through a malonate semialdehyde intermediate.

24. The method of claim 19 , wherein the dehydrogenase is 3-hydroxypropionate dehydrogenase.

25. A recombinant bacterium comprising a 3-hydroxypropionic acid (3-HP) pathway, wherein said bacterium is transformed with a heterologous nucleic acid that encodes 3-HP pathway enzymes and enhances a 3-HP bio-production process in said bacterium, wherein said 3-HP pathway enzymes comprise an oxaloacetate alpha-oxo-decarboxylase and a dehydrogenase, and wherein the bio-production of 3-HP is performed under microaerobic conditions.

26. A recombinant Escherichia coli bacterium, comprising a 3-hydroxypropionic acid (3-HP) pathway, wherein said bacterium is transformed with a heterologous nucleic acid that encodes 3-HP pathway enzymes, said 3-HP pathway enzymes comprise a 2-keto acid decarboxylase and a dehydrogenase and wherein production of 3-HP is enhanced as compared to a bacterium without the heterologous nucleic acid.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Oct 12, 2016
From: SILICON VALLEY BANK
To: OPX BIOTECHNOLOGIES, INC.
Reel/Frame 040746/0051 →
SECURITY INTEREST Recorded Apr 7, 2015
From: OPX BIOTECHNOLOGIES, INC.
To: SILICON VALLEY BANK
Reel/Frame 035350/0608 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INVENTORSHIP BY REMOVING INVENTOR INADVERTENTLY LISTED AS ASSIGNOR IN EARLIER CORRECTIVE ASSIGNMENT PREVIOUSLY RECORDED ON REEL 026246 FRAME 0874. ASSIGNOR(S) HEREBY CONFIRMS THE CORRECTIVE ASSIGNMENT. Recorded May 12, 2011
From: LYNCH, MICHAEL D.
To: OPX BIOTECHNOLOGIES, INC.
Reel/Frame 026268/0069 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INVENTORSHIP PREVIOUSLY RECORDED ON REEL 021986 FRAME 0332. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT OF ASSIGNOR'S INTEREST.. Recorded May 9, 2011
From: LYNCH, MICHAEL D; WARNECKE, TANYA E
To: OPX BIOTECHNOLOGIES, INC..
Reel/Frame 026246/0874 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 16, 2008
From: LYNCH, MICHAEL D; WARNECKE, TANYA E
To: OPX BIOTECHNOLOGIES, INC.
Reel/Frame 021986/0332 →
Continuity (1)
Provisional Application 60992290 · Dec 4, 2007